Evidence map›Paper›PMID 34539914›Full record

ArticleActa endocrinologica (Bucharest, Romania : 2005)

Adrenocortical System Hormones in Non-Critically Ill COVID-19 Patients.

I Ekinci, M Hursitoglu, M Tunc, C Kazezoglu, N Isiksacan, S Yurt, E Akdeniz, E Eroz, A Kumbasar

Open access · greenAbstract read
In one paragraph

Article in Acta endocrinologica (Bucharest, Romania : 2005). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. PITUITARY FUNCTIONS AFTER RECOVERY FROM COVID-19.Acta endocrinologica (Bucharest, Romania : 2005)
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

I EkinciUniversity of Health Sciences, Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Internal Medicine Dept.
M HursitogluUniversity of Health Sciences, Basaksehir Cam and Sakura State Hospital, Internal Medicine Dept.
M TuncBezmialem Vakif University, Internal Medicine Dept.
C KazezogluUniversity of Health Sciences, Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Biochemistry Dept.
N IsiksacanUniversity of Health Sciences, Biochemistry Dept., Bakirkoy Dr. Sadi Konuk Training and Research Hospital.
S YurtUniversity of Health Sciences, Basaksehir Cam and Sakura State Hospital, Pulmonary Medicine Dept.
E AkdenizMarmara University, Marmara Medical Faculty, Biostatistics Dept., Istanbul, Turkey.
E ErozUniversity of Health Sciences, Basaksehir Cam and Sakura State Hospital, Internal Medicine Dept.
A KumbasarUniversity of Health Sciences, Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Internal Medicine Dept.
Sağlık Bilimleri Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextThe effects of COVID-19 on the adrenocortical system and its hormones are not well known.

objectivesWe studied serum cortisol, serum adrenocorticotropic hormone (ACTH), and their ratio in hospitalized non-critically ill COVID-19 patients.

designA prospective case-control study.

methodsThe study participants were divided into 2 groups. Group 1 consisted of 74 COVID-19 patients. The second group consisted of 33 healthy persons. Early admission above hormones levels was determined and compared between the study groups. Besides that, COVID-19 patients were grouped according to their Glasgow Coma Score (GCS), CURB-65 score, and intensive care unit (ICU) requirement, and further sub-analyses were performed.

resultsThere were no significant differences in the mean age or gender distribution in both groups. In the patients' group, the serum ACTH concentration was lower than in the healthy group (p<0.05). On the other hand, the serum cortisol levels and cortisol/ACTH ratio of the patients' group were significantly higher than of the healthy controls (p<0.05, all). Further analyses showed that, although serum cortisol and ACTH levels were not high, the cortisol/ACTH ratio was higher in COVID-19 patients with low GCS (<15) than patients with normal GCS (=15) (p<0.05). In COVID-19 in patients with different CURB-65 scores, the cortisol/ACTH ratio was significantly different (p<0.05), while serum cortisol and ACTH were not different in groups (p>0.05). Serum cortisol levels and cortisol/ACTH ratio were higher but ACTH level was lower in the ICU needed COVID-19 patients than in patients who do not need ICU (p<0.05).

conclusionOur pilot study results showed that the cortisol/ACTH ratio would be more useful than serum cortisol and/or ACTH levels alone in evaluating the adrenocortical system of COVID-19 patients. Still, further detailed studies are needed to confirm these.

Indexed as

ACTHcoronaviruscortisolCOVID-19CURB-65pandemic

Identifiers

PMID34539914
PMCPMC8417496
OpenAlexW3196053891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.